Sarasota, Florida (PRWEB) July 12, 2010
Global-Med Technologies Group, Inc. (GTG) announced that the Company has signed an agreement with SMI of Ocala, Florida to provide manufacturing of all implants, instruments and related medical components for GTG's subsidiary companies. GTG currently has three subsidiary companies that are involved in the medical device industry. These companies will manufacture their orthopedic, spinal, diagnostic, neurosurgery and general medical instrumentation products at the new ISO 13485 certified SMI facility in Ocala, Florida
Further to this new strategic partnership, SMI will provide prototyping, manufacturing, design, testing, clean room environment, quality, distribution and inventory control services to these device companies. GTG will eventually gain space in these new facilities to interface with SMI and create a manufacturing engineering department (http://www.mosaicmedtech.com/resources.html) to liaison with its subsidiaries. This will allow SMI to grow its medical device manufacturing and service business in the US and internationally. SMI management believes that the US medical device industry ($100 billion) and the worldwide healthcare market ($4.2 trillion) provide one of the best manufacturing growth opportunities in the upcoming decades.
GTG is a research-based, technologies-driven holding group that develops medical devices within in its focused subsidiary companies. These entities operate primarily in the orthopedic and musculoskeletal device sector. The Company provides surgeons and health professionals with clinically relevant, innovative and cost-effective products that improve the quality of life for patients. The Company has a bias towards devices and procedures that are minimally invasive in nature and therefore, less traumatic to the patient. Visit http://www.global-med.us.com for more information about the Company.